Free Trial

NLS Pharmaceutics (NLSPW) Competitors

NLS Pharmaceutics logo
$0.02 0.00 (-0.50%)
As of 07/3/2025 12:56 PM Eastern

NLSPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ARAV, ACABW, BFRIW, and BTMDW

Should you be buying NLS Pharmaceutics stock or one of its competitors? The main competitors of NLS Pharmaceutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

NLS Pharmaceutics vs. Its Competitors

NLS Pharmaceutics (NASDAQ:NLSPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NLS PharmaceuticsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, NLS Pharmaceutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
NLS Pharmaceutics Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
NLS PharmaceuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

NLS Pharmaceutics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get NLS Pharmaceutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NLSPW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NLSPW vs. The Competition

MetricNLS PharmaceuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.96M$5.55B$9.05B
Dividend YieldN/A3.74%5.24%4.01%
P/E RatioN/A3.4027.6120.23
Price / SalesN/A4,084.30417.23118.52
Price / CashN/A13.1936.8958.10
Price / BookN/A42.828.035.67
Net IncomeN/A-$92.79M$3.18B$249.21M
7 Day PerformanceN/A2.48%2.93%3.28%
1 Month PerformanceN/A2.76%3.75%5.55%
1 Year PerformanceN/A189.37%35.20%21.09%

NLS Pharmaceutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NLSPW
NLS Pharmaceutics
N/A$0.02
-0.5%
N/A-33.3%$0.00N/A0.006
ATNFW
180 Life Sciences
N/A$0.01
+7.5%
N/A-19.8%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-13.3%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-47.3%$0.00$585.60M0.004Positive News
AMPE
Ampio Pharmaceuticals
0.0544 of 5 stars
$0.00
-96.3%
N/AN/A$0.00N/A0.0020Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/AN/A$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.01
+24.5%
N/A-97.9%$0.00$199.38M0.00N/AGap Down

Related Companies and Tools


This page (NASDAQ:NLSPW) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners